VandenBranden M - Search Results

1

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

Gorski JC, Hall SD, Jones DR, VandenBranden M, Wrighton SA. Gorski JC, et al. Among authors: vandenbranden m. Biochem Pharmacol. 1994 Apr 29;47(9):1643-53. doi: 10.1016/0006-2952(94)90543-6. Biochem Pharmacol. 1994. PMID: 8185679

2

Modulation of rat hepatic cytochromes P450 by chronic methapyrilene treatment.

Wrighton SA, VandenBranden M, Brown TJ, Van Pelt CS, Thomas PE, Shipley LA. Wrighton SA, et al. Among authors: vandenbranden m. Biochem Pharmacol. 1991 Aug 8;42(5):1093-7. doi: 10.1016/0006-2952(91)90293-e. Biochem Pharmacol. 1991. PMID: 1872894

3

Bimodal distribution of renal cytochrome P450 3A activity in humans.

Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD. Haehner BD, et al. Among authors: vandenbranden m. Mol Pharmacol. 1996 Jul;50(1):52-9. Mol Pharmacol. 1996. PMID: 8700118

4

Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.

Wrighton SA, Vandenbranden M, Becker GW, Black SD, Thomas PE. Wrighton SA, et al. Among authors: vandenbranden m. Mol Pharmacol. 1992 Jan;41(1):76-82. Mol Pharmacol. 1992. PMID: 1370708

5

Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).

Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, Vandenbranden M. Wrighton SA, et al. Among authors: vandenbranden m. Mol Pharmacol. 1990 Aug;38(2):207-13. Mol Pharmacol. 1990. PMID: 2385232

6

Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family.

Wrighton SA, Vandenbranden M. Wrighton SA, et al. Among authors: vandenbranden m. Arch Biochem Biophys. 1989 Jan;268(1):144-51. doi: 10.1016/0003-9861(89)90575-4. Arch Biochem Biophys. 1989. PMID: 2492179

7

Identification of a polymorphically expressed member of the human cytochrome P-450III family.

Wrighton SA, Ring BJ, Watkins PB, VandenBranden M. Wrighton SA, et al. Among authors: vandenbranden m. Mol Pharmacol. 1989 Jul;36(1):97-105. Mol Pharmacol. 1989. PMID: 2747634

8

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation.

Wrighton SA, Stevens JC, Becker GW, VandenBranden M. Wrighton SA, et al. Among authors: vandenbranden m. Arch Biochem Biophys. 1993 Oct;306(1):240-5. doi: 10.1006/abbi.1993.1506. Arch Biochem Biophys. 1993. PMID: 8215410

9

Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.

VandenBranden M, Ring BJ, Binkley SN, Wrighton SA. VandenBranden M, et al. Pharmacogenetics. 1996 Feb;6(1):81-91. doi: 10.1097/00008571-199602000-00007. Pharmacogenetics. 1996. PMID: 8845864

10

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.

Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA. Ring BJ, et al. Among authors: vandenbranden m. Br J Clin Pharmacol. 1996 Mar;41(3):181-6. doi: 10.1111/j.1365-2125.1996.tb00180.x. Br J Clin Pharmacol. 1996. PMID: 8866916 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters